LENZ Therapeutics, Inc. (LENZ)
3.20
-0.30
(-8.57%)
USD |
NASDAQ |
Nov 18, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
LENZ Therapeutics Profit Margin (Quarterly) : -915.2% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -915.2% |
| June 30, 2026 | -581.8% |
| March 31, 2026 | -2.18K% |
| Date | Value |
|---|---|
| December 31, 2025 | -2.26K% |
| September 30, 2025 | -133.6% |
| June 30, 2025 | -298.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| EyePoint, Inc. | -12.65K% |
| Ligand Pharmaceuticals, Inc. | -36.17% |
| Bristol Myers Squibb Co. | 16.53% |
| Context Therapeutics, Inc. | -- |
| Neumora Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.74% |
| Return on Assets | -56.77% |
| Return on Invested Capital | -61.55% |
| Gross Profit Margin (Quarterly) | 86.58% |
| Operating Margin (Quarterly) | -972.8% |
| Return on Net Operating Assets | -2.30K% |